364 related articles for article (PubMed ID: 1671393)
1. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells.
Beasley D; Schwartz JH; Brenner BM
J Clin Invest; 1991 Feb; 87(2):602-8. PubMed ID: 1671393
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.
Beasley D; McGuiggin M
J Exp Med; 1994 Jan; 179(1):71-80. PubMed ID: 7505803
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
Singh A; Sventek P; Larivière R; Thibault G; Schiffrin EL
Am J Hypertens; 1996 Sep; 9(9):867-77. PubMed ID: 8879343
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
Marsden PA; Ballermann BJ
J Exp Med; 1990 Dec; 172(6):1843-52. PubMed ID: 1979590
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 induces prostacyclin-dependent increases in cyclic AMP production and does not affect cyclic GMP production in human vascular smooth muscle cells.
Beasley D; McGuiggin ME
Cytokine; 1995 Jul; 7(5):417-26. PubMed ID: 7578979
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle.
Beasley D
Am J Physiol; 1990 Jul; 259(1 Pt 2):R38-44. PubMed ID: 1695820
[TBL] [Abstract][Full Text] [Related]
7. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
8. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells.
Kusano E; Tian S; Umino T; Tetsuka T; Ando Y; Asano Y
J Hypertens; 1997 Jun; 15(6):627-32. PubMed ID: 9218182
[TBL] [Abstract][Full Text] [Related]
9. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells.
Durante W; Schini VB; Scott-Burden T; Junquero DC; Kroll MH; Vanhoutte PM; Schafer AI
Am J Physiol; 1991 Dec; 261(6 Pt 2):H2024-30. PubMed ID: 1661096
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway.
Kolb JP; Paul-Eugene N; Damais C; Yamaoka K; Drapier JC; Dugas B
J Biol Chem; 1994 Apr; 269(13):9811-6. PubMed ID: 7511593
[TBL] [Abstract][Full Text] [Related]
11. L-arginine stimulates cyclic guanosine 3',5'-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: evidence for L-arginine:nitric oxide synthase.
Laychock SG; Modica ME; Cavanaugh CT
Endocrinology; 1991 Dec; 129(6):3043-52. PubMed ID: 1683279
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
Mollace V; Salvemini D; Anggard E; Vane J
Br J Pharmacol; 1991 Nov; 104(3):633-8. PubMed ID: 1724627
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells.
Inoue T; Fukuo K; Morimoto S; Koh E; Ogihara T
Biochem Biophys Res Commun; 1993 Jul; 194(1):420-4. PubMed ID: 8392840
[TBL] [Abstract][Full Text] [Related]
14. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
[TBL] [Abstract][Full Text] [Related]
15. Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential.
Kahn AM; Allen JC; Seidel CL; Lichtenberg DS; Song T; Zhang S
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E627-33. PubMed ID: 10751195
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide enhances PGI(2)production by human pulmonary artery smooth muscle cells.
Wen F; Watanabe K; Yoshida M
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):369-78. PubMed ID: 10913230
[TBL] [Abstract][Full Text] [Related]
17. Adrenergic stimulation of cyclic GMP formation requires NO-dependent activation of cytosolic guanylate cyclase in rat pinealocytes.
Spessert R; Layes E; Vollrath L
J Neurochem; 1993 Jul; 61(1):138-43. PubMed ID: 8099948
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction.
Corbett JA; Wang JL; Hughes JH; Wolf BA; Sweetland MA; Lancaster JR; McDaniel ML
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):229-35. PubMed ID: 1384465
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-releasing factor increases somatostatin release and mRNA levels in the rat periventricular nucleus via nitric oxide by activation of guanylate cyclase.
Aguila MC
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):782-6. PubMed ID: 7904758
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells.
Marumo T; Nakaki T; Hishikawa K; Hirahashi J; Suzuki H; Kato R; Saruta T
Endocrinology; 1995 May; 136(5):2135-42. PubMed ID: 7536663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
